Review
The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs
Harold Kalant
CMAJ October 02, 2001 165 (7) 917-928;
Harold Kalant
Dr. Kalant is Professor Emeritus, Department of Pharmacology, University of Toronto, and Addiction Research Foundation Division, Centre for Addiction and Mental Health, Toronto, Ont.
Submit a Response to This Article
Jump to comment:
No Responses have been published for this article.
In this issue
CMAJ
Vol. 165, Issue 7
2 Oct 2001
Article tools
The pharmacology and toxicology of “ecstasy” (MDMA) and related drugs
Harold Kalant
CMAJ Oct 2001, 165 (7) 917-928;
Jump to section
Related Articles
Cited By...
- Unlocking the Potential of High-Quality Dopamine Transporter Pharmacological Data: Advancing Robust Machine Learning-Based QSAR Modeling
- Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms
- MDMA-Associated Liver Toxicity: Pathophysiology, Management, and Current State of Knowledge
- Stroboscopic light effects during electronic dance music festivals and photosensitive epilepsy: a cohort study and case report
- Chiral Plasma Pharmacokinetics of 3,4-Methylenedioxymethamphetamine and its Phase I and II Metabolites following Controlled Administration to Humans
- Critical Role of Peripheral Vasoconstriction in Fatal Brain Hyperthermia Induced by MDMA (Ecstasy) under Conditions That Mimic Human Drug Use
- Urinary Excretion Kinetics of 3,4-Methylenedioxymethamphetamine (MDMA, Ecstasy) and Its Phase I and Phase II Metabolites in Humans following Controlled MDMA Administration
- Investigation on the Enantioselectivity of the Sulfation of the Methylenedioxymethamphetamine Metabolites 3,4-Dihydroxymethamphetamine and 4-Hydroxy-3-Methoxymethamphetamine using the Substrate-Depletion Approach
- Metabolism and Disposition of 3,4-Methylenedioxymethamphetamine ("Ecstasy") in Baboons after Oral Administration: Comparison with Humans Reveals Marked Differences
- Ecstasy-induced thyrotoxic periodic paralysis
- The Role of Human UDP-Glucuronyltransferases on the Formation of the Methylenedioxymethamphetamine (Ecstasy) Phase II Metabolites R- and S-3-Methoxymethamphetamine 4-O-Glucuronides
- The Role of Human Hepatic Cytochrome P450 Isozymes in the Metabolism of Racemic 3,4-Methylenedioxyethylamphetamine and Its Single Enantiomers
- The Role of Human Hepatic Cytochrome P450 Isozymes in the Metabolism of Racemic 3,4-Methylenedioxy-Methamphetamine and Its Enantiomers
- Negative-Ion Chemical Ionization Gas Chromatography-Mass Spectrometry Assay for Enantioselective Measurement of Amphetamines in Oral Fluid: Application to a Controlled Study with MDMA and Driving Under the Influence Cases
- Seizures and substance abuse: Treatment considerations
- Nightclubs and the seven deadly sins
- Drug Testing in Blood: Validated Negative-Ion Chemical Ionization Gas Chromatographic-Mass Spectrometric Assay for Enantioselective Measurement of the Designer Drugs MDEA, MDMA, and MDA and Its Application to Samples from a Controlled Study with MDMA
- Pharmacological Characterization of Ecstasy Synthesis Byproducts with Recombinant Human Monoamine Transporters
- Brain Hyperthermia Is Induced by Methamphetamine and Exacerbated by Social Interaction